Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
714
NCT02482324
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2015
Completion: Jul 31, 2015
NCT02547818
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Phase: Phase 3
Start: Sep 15, 2015
Completion: Nov 18, 2020
NCT04570644
Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers
Start: Aug 28, 2020
Completion: Jan 18, 2021
NCT04428775
A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease
Phase: Phase 2
Start: Sep 8, 2020
Completion: Oct 1, 2021
NCT03202147
Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
Start: Dec 31, 2023
Completion: Dec 31, 2024